📣 VC round data is live. Check it out!

Bunge Valuation Multiples

Discover Bunge's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Qinghai Salt Lake Industry, Novonesis, Industries Qatar, US Foods and more.

Bunge Overview

About Bunge

Bunge Global SA is an agribusiness solutions company, connecting farmers to consumers and delivering essential food, feed and fuel to the globe. The company segments include Soybean Processing and Refining; Softseed Processing and Refining; Other Oilseeds Processing and Refining; Grain Merchandising and Milling; and Corporate and Other. It generates maximum revenue from the Soybean Processing and Refining segment, which includes integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybeans and soybean related products, as well as biodiesel and fertilizer production and distribution. Geographically, the company operates in United States, Switzerland, Netherlands, and Rest of the World.


Founded

1818

HQ

United States

Employees

34.0K

Website

bunge.com

Financials (LTM)

Revenue: $79B
EBITDA: $3B

EV

$40B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Bunge Financials

Bunge reported last 12-month revenue of $79B and EBITDA of $3B.

In the same LTM period, Bunge generated $4B in gross profit, $3B in EBITDA, and $1B in net income.

Revenue (LTM)


Bunge P&L

In the most recent fiscal year, Bunge reported revenue of $70B and EBITDA of $3B.

Bunge is profitable as of last fiscal year, with gross margin of 5%, EBITDA margin of 4%, and net margin of 2%.

See analyst estimates for Bunge
LTMLast FY202320242025202620272028
Revenue$79B$70B$60B$53B$70B
Gross Profit$4B$3B$5B$3B$3B
Gross Margin5%5%8%6%5%
EBITDA$3B$3B$4B$2B$2B
EBITDA Margin4%4%7%5%4%
EBIT Margin3%3%5%3%2%
Net Profit$1B$1B$2B$1B$816M
Net Margin2%2%4%2%1%
Net Debt-$13B---

Financial data powered by Morningstar, Inc.

Bunge Stock Performance

Bunge has current market cap of $25B, and enterprise value of $40B.

Market Cap Evolution


Bunge's stock price is $129.97.

Bunge share price increased by 5.4% in the last 30 days, and by 61.9% in the last year.

Bunge has an EPS (earnings per share) of $6.49.

See more trading valuation data for Bunge
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$40B$25B5.4%5.4%2.2%61.9%$6.49

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Bunge Valuation Multiples

Bunge trades at 0.5x EV/Revenue multiple, and 12.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Bunge

EV / Revenue (LTM)


Bunge Financial Valuation Multiples

As of June 2, 2026, Bunge has market cap of $25B and EV of $40B.

Bunge has a P/E ratio of 17.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.5x0.6x0.7x0.7x0.6x
EV/EBITDA12.6x14.9x9.9x16.2x16.1x
EV/EBIT17.4x21.3x12.7x24.6x30.7x
EV/Gross Profit9.9x11.7x8.2x11.7x11.7x
P/E17.2x20.0x11.2x22.2x30.9x
EV/FCF155.8x(73.0x)18.2x76.0x(45.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Bunge Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Bunge Margins & Growth Rates

Bunge grew revenue by 31% and EBITDA by 44% in the last fiscal year.

In the most recent fiscal year, Bunge reported gross margin of 5%, EBITDA margin of 4%, and net margin of 2%.

See estimated margins and future growth rates for Bunge

Bunge Margins

Last FY202420252026202720282029
Gross Margin5%6%5%5%
EBITDA Margin4%5%4%4%
EBIT Margin3%3%2%3%
Net Margin2%2%1%2%
FCF Margin(1%)1%(1%)1%

Bunge Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth31%(11%)32%31%
Gross Profit Growth25%(30%)0%25%
EBITDA Growth44%(39%)0%56%
EBIT Growth53%(48%)(20%)121%
Net Profit Growth40%(49%)(28%)116%
FCF Growth(350%)(76%)(268%)(255%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Bunge Operational KPIs

Bunge's revenue per employee in the last FY averaged $2.1M, while opex per employee averaged $0.1M for the same period.

Bunge's Rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bunge's Rule of X is 81% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Bunge
LTMLast FY202320242025202620272028
Rule of 4022%35%---
Bessemer Rule of X49%81%---
Revenue per Employee-$2.1M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue0%0%--0%
Opex to Revenue-3%3%3%3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Bunge Competitors

Bunge competitors include Qinghai Salt Lake Industry, Novonesis, Industries Qatar, US Foods, Bollore, Wilmar International, CF Industries, Wesco, Nutrien and SABIC Agri-Nutrient.

Most Bunge public comparables operate across Agriculture and Wholesale Distribution.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Qinghai Salt Lake Industry8.7x6.6x16.3x11.8x
Novonesis6.2x6.1x16.8x16.4x
Industries Qatar4.0x4.3x10.4x13.1x
US Foods0.6x0.6x12.0x11.5x
Bollore3.3x3.3x21.7x52.4x
Wilmar International0.5x0.5x8.2x9.5x
CF Industries2.7x2.5x5.8x5.4x
Wesco1.0x1.0x15.1x14.3x

This data is available for Pro users. Sign up to see all Bunge competitors and their valuation data.

Start Free Trial

Acquisitions by Bunge

Bunge has acquired 5 companies to date.

Last acquisition by Bunge was on March 1st 2026. Bunge acquired IFF (soy protein, lecithin, and crush unit) for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Bunge

IFF (soy protein, lecithin, and crush unit)
CJ Selecta
Viterra
IOI Loders Croklaan
Description
IFF’s Soy Protein Concentrate, Lecithin, and Crush Business produces soy protein concentrates and lecithin through soybean crushing. Food manufacturers and industrial buyers purchase these plant-based ingredients. The unit belongs to International Flavors & Fragrances Inc.’s nutrition and biosciences division.
CJ Selecta is a São Paulo-based manufacturer of soy-based products including textured vegetable proteins, soy flours, and lecithins for food processing and animal feed industries. It supplies ingredients to Nestlé Brazil and local meat processors using GMO-free soybeans sourced from Mato Grosso farms. The company operates a production facility in Salto with sustainability certifications for water recycling and waste reduction.
Viterra is a Regina, Saskatchewan-headquartered grain handler marketing canola, wheat, and pulses from Canadian prairies to Asia and Europe. Owned by Glencore, it operates 50 primary elevators and port terminals in Vancouver and Prince Rupert. Viterra transports 20 million tonnes annually via rail to export markets including Japan and China.
IOI Loders Croklaan is a global supplier of specialty vegetable oils and fats for food manufacturers. Produced from palm, shea, and soy sources, its products serve bakery, confectionery, and ice cream industries. Headquartered in Rotterdam, Netherlands, the company operates 15 factories across five continents. Acquired by IOI Group in 2015, it supplies brands like Unilever and Nestlé.
HQ Country-BrazilCanadaUnited States
HQ City
-
Uberlândia
Regina
Chicago, IL
Deal Date1 Mar 202610 Oct 202313 Jun 202312 Sep 2017
Valuationundisclosed$539M$8B$1B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Bunge acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Bunge

Bunge has invested in 4 companies to date.

Latest investment by Bunge was on April 13th 2021. Bunge invested in Australian Plant Proteins in their $46M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Bunge

Australian Plant Proteins
Nanoguard Technologies
MycoTechnology
SafeTraces
Description
Australian Plant Proteins is a Werribee-based manufacturer of pea and faba bean protein isolates derived from Victorian pulses since 2019. It produces 5,000 tonnes annually of 85% protein powders for sports nutrition and food fortification, supplying brands like Sanitarium and international exporters. The facility features high-shear extrusion and spray drying lines compliant with HACCP standards.
Nanoguard Technologies is a provider of Airilization systems for non-thermal pathogen elimination. The energized air technology inactivates bacteria, viruses, mold, and fungi on surfaces and in HVAC systems within minutes, used in healthcare, food processing, and transportation for continuous disinfection.
MycoTechnology is a fungi-based processing company incorporated in 2013 and based in Aurora, Colorado. The firm ferments agricultural products with gourmet mushroom strains to enhance flavors, launching ClearTaste as an organic bitter blocker certified Kosher and Halal for beverages and foods. MycoTechnology myceliates robusta and arabica coffee beans, chocolate, and other crops, licensing technology to roasters worldwide. Its platform addresses bitterness in stevia, coffee, and cacao, improving taste profiles without synthetic additives.
SafeTraces is a US biotechnology company offering a data analytics platform for pathogen detection and prevention. Based in Richmond, California, it uses synthetic DNA tracers to track contamination in water systems and food supplies for public health agencies.
HQ CountryAustraliaUnited StatesUnited StatesUnited States
HQ City
Melbourne
Saint Louis, MO
Chicago, IL
San Francisco, CA
Deal Date13 Apr 202113 May 201930 Jan 201917 Oct 2018
RoundSeedSeries ASeries CSeries A
Raised$46M$6M$30M$10M
InvestorsBungeBunge; Cultivation Capital; Fulcrum Global Capital; Maumee Ventures; The Yield LabBunge; Cibus Fund; Continental Grain Company; DNS-Hiitake; Eighteen94 Capital; Middleland MT Holdings; S2G Investments; TMI Investments BV; Tyson VenturesBunge; S2G Investments; Spero Ventures; UL Ventures
Valuationundisclosedundisclosedundisclosed$34M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Bunge investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Bunge

When was Bunge founded?Bunge was founded in 1818.
Where is Bunge headquartered?Bunge is headquartered in United States.
How many employees does Bunge have?As of today, Bunge has over 34K employees.
Who is the CEO of Bunge?Bunge's CEO is Gregory A. Heckman.
Is Bunge publicly listed?Yes, Bunge is a public company listed on NYSE.
What is the stock symbol of Bunge?Bunge trades under BG ticker.
When did Bunge go public?Bunge went public in 2001.
Who are competitors of Bunge?Bunge main competitors include Qinghai Salt Lake Industry, Novonesis, Industries Qatar, US Foods, Bollore, Wilmar International, CF Industries, Wesco, Nutrien, SABIC Agri-Nutrient.
What is the current market cap of Bunge?Bunge's current market cap is $25B.
What is the current revenue of Bunge?Bunge's last 12 months revenue is $79B.
What is the current revenue growth of Bunge?Bunge revenue growth (NTM/LTM) is 18%.
What is the current EV/Revenue multiple of Bunge?Current revenue multiple of Bunge is 0.5x.
What is the current EBITDA of Bunge?Bunge's last 12 months EBITDA is $3B.
What is Bunge's EBITDA margin?Bunge's last 12 months EBITDA margin is 4%.
What is the current EV/EBITDA multiple of Bunge?Current EBITDA multiple of Bunge is 12.6x.
What is the current FCF of Bunge?Bunge's last 12 months FCF is $255M.
What is Bunge's FCF margin?Bunge's last 12 months FCF margin is 0%.
What is the current EV/FCF multiple of Bunge?Current FCF multiple of Bunge is 155.8x.
How many companies Bunge has acquired to date?As of June 2026, Bunge has acquired 5 companies.
What was the largest acquisition by Bunge?$8B acquisition of Viterra on 13th June 2023 was the largest M&A Bunge has done to date.
What companies Bunge acquired?Bunge acquired Viterra, IOI Loders Croklaan, CJ Selecta, Ana Gıda, and IFF (soy protein, lecithin, and crush unit).
In how many companies Bunge has invested to date?As of June 2026, Bunge has invested in 4 companies.
What was the last Bunge investment?On 13th April 2021 Bunge invested in Australian Plant Proteins, participating in a $46M Seed round.
In what companies Bunge invested in?Bunge invested in Australian Plant Proteins, MycoTechnology, SafeTraces, and Nanoguard Technologies.

See public comps similar to Bunge

Lists including Bunge

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial